Cell and Gene Therapy Deals, 2022

$5,000.00$10,000.00

Description:

The cell and gene therapy (CGT) sector has experienced remarkable growth, with funding reaching $70 billion in 2021. As barriers to entry lower and the number of approved therapies with proven track records increases, over a thousand companies have entered or expanded within this dynamic field. Keeping up with this rapidly evolving industry is essential, and Kalorama Information’s latest report, Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments, 2022, provides comprehensive insights into the myriad deals shaping the CGT landscape.

Key Highlights:

  • Funding and Investments: Detailed analysis of the financial influx into CGT-related companies, including IPOs, SPACs, venture capital, and private funding.
  • Strategic Deals: Insight into mergers & acquisitions, strategic investments, technology and research collaborations, and licensing agreements.
  • Operational Transactions: Examination of manufacturing and supply chain deals, public outreach efforts, consumer education, philanthropy, and distribution partnerships.
  • Market Dynamics: Breakdown of restructurings, joint ventures, terminations, and spinoffs impacting the CGT sector.
  • Quarterly Analysis: Charts illustrating the frequency and types of deals throughout 2021, providing a clear view of market trends and activity changes per quarter.

Why This Report is Essential:

  • Comprehensive Coverage: Tracks hundreds of cell and gene therapy deals, categorizing them into a usable format for easy reference.
  • Market Insight: Offers in-depth analysis of key deals and strategic movements within the CGT industry.
  • Investor Guidance: Provides valuable information for investors looking to understand the funding landscape and identify opportunities.

Additional Features:

  • Vendor Profiles: Detailed profiles of leading companies involved in the CGT market.
  • Visual Data Representation: Charts and graphs that visually represent deal activities and trends.
  • Expert Analysis: Insights from Kalorama’s experienced analysts, offering expert perspectives on market developments.

For further details and to purchase directly, please contact us.

Sample Report: A sample is available as a PDF upon request.

 

 

 

Table: Total Quarterly Funding, By 2021 Quarter, By Type of Funding (in millions $) (%)

Category Q1 Q2 Q3 Q4 Total %
M&A $XX Million $XX Million $XX Million $XX Million $XX Million XX%
VC/ Private $XX Million $XX Million $XX Million $XX Million $XX Million XX%
IPO/ FPO $XX Million $XX Million $XX Million $XX Million $XX Million XX%
SPAC $XX Million $XX Million $XX Million $XX Million $XX Million XX%
Strat. Investment* $XX Million $XX Million $XX Million $XX Million $XX Million XX%
Total $XX Million $XX Million $XX Million $XX Million $XX Million XX%

Source: Kalorama Information

LICENSE

, ,